Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
SI-BONE to Present at the 40th Annual Canaccord Genuity Growth Conference
-
SI-BONE to Present at the 40th Annual Canaccord Genuity Growth Conference
-
ZoomInfo to Participate in Investor Conference on Thursday, August 13th
-
Itron to Present at Oppenheimer’s 23rd Annual Technology, Internet and Communications Conference and Canaccord Genuity’s 40th Annual Growth Conference
-
T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference
-
Shopify (SHOP:CN) (SHOP) PT Raised to $1,000 at Canaccord Genuity, Following Earnings
-
Teladoc (TDOC) PT Raised to $255 at Canaccord Genuity As 2Q has Outperformed on Every Level
-
PayPal (PYPL) PT Raised to $218 at Canaccord Genuity, Following Earnings
-
Qualcomm (QCOM) PT Raised to $137 at Canaccord Genuity, Following Earnings
-
Open Lending to Present at the Canaccord Genuity Virtual Growth Conference
-
Misonix to Present at the 40th Annual Canaccord Genuity Growth Conference
-
Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference
-
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
-
GBT Announces Participation in Upcoming Investor Conferences
-
Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020
-
CloudMD to Present at Canaccord Genuity 40th Annual Growth Conference
-
Theratechnologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020
-
TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference
-
TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference
-
CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference
-
Karuna Therapeutics to Present at Upcoming Investor Conferences
-
Amended Bid Implementation Agreement – Shandong Gold
-
Genetron Health to Present at Canaccord Genuity 40th Annual Growth Conference
-
Genetron Health to Present at Canaccord Genuity 40th Annual Growth Conference
-
ImmunoGen Announces Webcast of Presentation at Upcoming Canaccord Genuity Virtual Growth Conference
-
Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Quidel to Present Virtually at the Canaccord Genuity 40th Annual Growth Conference
-
Penumbra, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
CalAmp To Participate at Upcoming Financial Conferences
-
iRhythm Technologies to Present at the 40th Annual Canaccord Genuity Global Growth Conference
-
AVITA Therapeutics to Participate at the Canaccord Genuity 40th Annual Growth Conference
-
Inari Medical to Present at the Canaccord Genuity 40th Annual Growth Conference
-
LeMaitre Vascular to Present at Upcoming Investor Conferences
-
Transaction in Own Shares
-
BlueCity to Participate in Upcoming Investor Conferences
-
BlueCity to Participate in Upcoming Investor Conferences
-
Caldas Gold Announces Closing of CA$50 Million Bought Deal Private Placement of Special Warrants
-
AtriCure to Participate at Upcoming Investor Conferences
-
IPG Photonics to Participate in Upcoming Investor Conference
-
Aphria Inc. Announces Fourth Quarter and Fiscal Year 2020 Results
-
Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Immunic, Inc. to Participate in Investor Conferences in August
-
Net Asset Value(s)
-
Aphria Inc. (APHA) Announces Fourth Quarter and Fiscal Year 2020 Results
-
Elemental Royalties Corp. (formerly Fengro Industries Corp.) Completes Business Combination
-
Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020
-
Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020

